Selected article for: "asymptomatic infection and sore throat"

Author: Thangavel, Rajagowthamee R.; Bouvier, Nicole M.
Title: Animal models for influenza virus pathogenesis, transmission, and immunology
  • Cord-id: 038h1ubm
  • Document date: 2014_4_4
  • ID: 038h1ubm
    Snippet: In humans, infection with an influenza A or B virus manifests typically as an acute and self-limited upper respiratory tract illness characterized by fever, cough, sore throat, and malaise. However, influenza can present along a broad spectrum of disease, ranging from sub-clinical or even asymptomatic infection to a severe primary viral pneumonia requiring advanced medical supportive care. Disease severity depends upon the virulence of the influenza virus strain and the immune competence and pre
    Document: In humans, infection with an influenza A or B virus manifests typically as an acute and self-limited upper respiratory tract illness characterized by fever, cough, sore throat, and malaise. However, influenza can present along a broad spectrum of disease, ranging from sub-clinical or even asymptomatic infection to a severe primary viral pneumonia requiring advanced medical supportive care. Disease severity depends upon the virulence of the influenza virus strain and the immune competence and previous influenza exposures of the patient. Animal models are used in influenza research not only to elucidate the viral and host factors that affect influenza disease outcomes in and spread among susceptible hosts, but also to evaluate interventions designed to prevent or reduce influenza morbidity and mortality in man. This review will focus on the three animal models currently used most frequently in influenza virus research – mice, ferrets, and guinea pigs – and discuss the advantages and disadvantages of each.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and acid inducible gene: 1
    • accessory protein and acute infection: 1, 2, 3, 4, 5, 6
    • accessory protein and acute lung injury: 1
    • accessory protein and live virus: 1, 2
    • accessory protein and low pathogenicity: 1
    • accessory protein and low pathogenicity avian influenza: 1
    • accessory protein and lung cardiovascular: 1
    • accessory protein and lung cardiovascular disease: 1
    • accessory protein and lung injury: 1, 2
    • accessory protein and lung injury acute: 1
    • accessory protein and lung pathology: 1, 2
    • accessory protein and macrophage activation: 1